Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $26.62 million. The enterprise value is -$6.31 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.42 million shares outstanding. The number of shares has increased by 2.17% in one year.
| Current Share Class | 35.42M |
| Shares Outstanding | 35.42M |
| Shares Change (YoY) | +2.17% |
| Shares Change (QoQ) | +3.79% |
| Owned by Insiders (%) | 19.77% |
| Owned by Institutions (%) | 7.34% |
| Float | 17.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | n/a |
| PB Ratio | 1.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.08 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.67% and return on invested capital (ROIC) is -23.79%.
| Return on Equity (ROE) | -33.67% |
| Return on Assets (ROA) | -11.95% |
| Return on Capital (ROIC) | -23.79% |
| Revenue Per Employee | $968,705 |
| Profits Per Employee | -$189,045 |
| Employee Count | 44 |
| Asset Turnover | 0.84 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $512,000 in taxes.
| Income Tax | 512,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.18% in the last 52 weeks. The beta is 1.83, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +47.18% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 36.71 |
| Average Volume (20 Days) | 302,918 |
Short Selling Information
The latest short interest is 218,040, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 218,040 |
| Short Previous Month | 190,494 |
| Short % of Shares Out | 0.62% |
| Short % of Float | 1.21% |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, Equillium had revenue of $42.62 million and -$8.32 million in losses. Loss per share was -$0.24.
| Revenue | 42.62M |
| Gross Profit | 42.62M |
| Operating Income | -9.72M |
| Pretax Income | -7.81M |
| Net Income | -8.32M |
| EBITDA | -9.58M |
| EBIT | -9.72M |
| Loss Per Share | -$0.24 |
Full Income StatementBalance Sheet
The company has $33.30 million in cash and $609,000 in debt, giving a net cash position of $32.69 million or $0.92 per share.
| Cash & Cash Equivalents | 33.30M |
| Total Debt | 609,000 |
| Net Cash | 32.69M |
| Net Cash Per Share | $0.92 |
| Equity (Book Value) | 22.43M |
| Book Value Per Share | 0.63 |
| Working Capital | 21.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.64 million and capital expenditures -$131,000, giving a free cash flow of -$15.77 million.
| Operating Cash Flow | -15.64M |
| Capital Expenditures | -131,000 |
| Free Cash Flow | -15.77M |
| FCF Per Share | -$0.45 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -22.79% and -19.52%.
| Gross Margin | 100.00% |
| Operating Margin | -22.79% |
| Pretax Margin | -18.31% |
| Profit Margin | -19.52% |
| EBITDA Margin | -22.49% |
| EBIT Margin | -22.79% |
| FCF Margin | -37.01% |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.17% |
| Shareholder Yield | -2.17% |
| Earnings Yield | -31.53% |
| FCF Yield | -59.79% |
Analyst Forecast
The average price target for Equillium is $5.00, which is 565.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 565.43% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -4.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.12 |
| Piotroski F-Score | 1 |